Concepedia

Kevin Parris

KP

Statistics

Publications

36

Citations

2.2K

H-Index

27

Active since

1983

Affiliations

Pfizer (United States)(Current)

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

University of Pittsburgh

WuXi AppTec (China)

Kevin Parris is an author at Pfizer (United States) specializing in medicinal chemistry, life sciences, and enzyme inhibition.

Publications per year

1983–2021

36

Publications

36

Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites

Kevin Parris, Laura Lin, Amy Tam et al. · Structure · 2000 · 222 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Molecular recognition with convergent functional groups. VI. Synthetic and structural studies with a model receptor for nucleic acid components

Ben Askew, Pablo Ballester, Chris A. Buhr et al. · Journal of the American Chemical Society · 1989 · 173 citations

Pharmacy, Biochemistry, Molecular Biology +16

Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications

Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam et al. · Journal of Medicinal Chemistry · 2014 · 132 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Crystal Structures of a Mutant (βK87T) Tryptophan Synthase α<sub>2</sub>β<sub>2</sub> Complex with Ligands Bound to the Active Sites of the α- and β-Subunits Reveal Ligand-Induced Conformational Changes

Sangkee Rhee, Kevin Parris, C. Craig Hyde et al. · Biochemistry · 1997 · 124 citations

Life Sciences, Biochemistry, Molecular Biology +17

Convergent functional groups: synthetic and structural studies

Julius Rebek, L. Marshall, R. Wolak et al. · Journal of the American Chemical Society · 1985 · 122 citations

Natural Sciences, Chemistry, Functional Materials +9

1–5 of 36